Drug
Who makes metformin hydrochloride extended-release tablets?
3 companies list metformin hydrochloride extended-release tablets as a human prescription drug. Forms: tablet, film coated, extended release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing metformin hydrochloride extended-release tablets
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| ScieGen Pharmaceuticals India Private LimitedIndia | tablet, film coated, extended release | ANDAANDA213334, ANDA214629 | 4 | 3 |
| AiPing Pharmaceutical, Inc.United States | tablet, film coated, extended release | ANDAANDA209993 | 2 | 1 |
| Qingdao BAHEAL Pharmaceutical Co., Ltd. | tablet, film coated, extended release | ANDAANDA209993 | 2 | 0 |
Enquiry
Common questions
- Who makes metformin hydrochloride extended-release tablets?
- 3 companies list metformin hydrochloride extended-release tablets as a human prescription drug in the openFDA NDC Directory, led by ScieGen Pharmaceuticals India Private Limited, AiPing Pharmaceutical, Inc., Qingdao BAHEAL Pharmaceutical Co., Ltd.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic metformin hydrochloride extended-release tablets?
- 3 companies list metformin hydrochloride extended-release tablets under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.